Article Detail - JE Part B
Colon Capsule Endoscopy (CCE) Final LCD - R1 - Effective December 19, 2021
This Local Coverage Determination (LCD) has completed the Open Public Meeting comment period and is now finalized under contractor numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, and NMI), and 01312 (NV).
|Medicare Coverage Database Number||LCD Title|
|L38824||Colon Capsule Endoscopy (CCE)|
|Medicare Coverage Database Number||Billing and Coding Article Title|
|A58436||Billing and Coding: Colon Capsule Endoscopy (CCE)|
|A58944||Response to Comments: Colon Capsule Endoscopy (CCE)|
Effective Date: December 19, 2021
Summary: This LCD provides limited coverage for a Diagnostic Colon Capsule endoscopy (CCE). Colon capsule endoscopy (CCE) is a noninvasive procedure that does not require air inflation or sedation and allows for minimally invasive and painless colonic evaluation. CCE utilizes a tiny wireless camera that takes pictures of the gastrointestinal tract. The wireless camera is housed inside a vitamin-size capsule that is swallowed with water. As the capsule travels through the digestive tract, the camera system takes pictures. The images are then transmitted to a computer with special software where the images are strung together to create a video. The provider reviews the video to look for any abnormalities within the gastrointestinal tract. The LCD was updated to acknowledge FDA approved blood-based biomarker testing that could be used for screening purposes.
Visit the CMS Medicare Coverage Database (MCD) to access this LCD.
Last Updated Tue, 09 Nov 2021 19:54:43 +0000